A new COVID variant is spreading in the US: What are the symptoms?
A new COVID-19 variant that was unheard of just months ago is now projected to be the second-most common strain in the U.S.
Variant NB.1.8.1 was first detected in China in January but accounted for about 0% of cases in the U.S. until May. By early June, it was estimated to account for up to 37%, according to the U.S. Centers for Disease Control (CDC).
The World Health Organization (WHO) evaluated the additional public health risk posed by the variant as "low at the global level in a May report, in which it also advised that currently approved COVID-19 vaccines are "expected to remain effective to this variant against symptomatic and severe disease."
Here's what we know about NB.1.8.1.
'Razor blade throat': What to know about COVID-19 variant NB.1.8.1
What is NB.1.8.1?
NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY in May.
The new variant was first detected in January in China. As of mid-May, the variant had reached 10.7% of global reported COVID-19 cases, according to the World Health Organization (WHO).
Verma previously said NB.1.8.1 may be able to be transferred more easily than LP.8.1. Additionally, he said that NB.1.8.1 is able to evade antibodies created by vaccines or past infections more easily than LP.8.1.
"NB.1.8.1 is likely to spread more rapidly and evade our immune defenses more easily than LP.8.1, which is why this variant requires careful monitoring," Verma said.
How common is NB.1.8.1?
For a two-week period starting on May 25 and ending on June 7, the CDC's Nowcast estimates tracker shows projections for the different COVID-19 variants. According to the latest CDC data, the NB.1.8.1 strain is projected to be the second highest in the U.S., making up 37% of the total cases recorded in the U.S.
The most common strain is LP.8.1, also known as Omicron, which accounts for 38% of cases, followed by NB.1.8.1 with 37%, XFG with 8%, XFC making up 7%, and LF.7.9 with 4%.
The prominence of NB.1.8.1 in the U.S. has significantly increased in recent weeks, accounting for 0% of cases through March before reaching 2% in April, 5% in early May and 15% by late May.
What are the symptoms of NB.1.8.1?
The CDC has not outlined symptoms that are specific to the NB.1.8.1. variant. Verma said that NB.1.8.1 symptoms appear similar to those of earlier COVID-19 variants.
However, an extremely sore throat, colloquially called "razor blade throat," has been associated with the new variant.
People with the variant have reported a feeling akin to their throats being covered with razor blades, according to the Los Angeles Times, Fox News, SF Gate, and other news outlets. Many people have also taken to social media to describe the "razor blade throat."
The CDC outlines the following as common COVID-19 symptoms:
The CDC advises seeking medical care if you experience any of the following symptoms:
How can you protect yourself from NB.1.8.1 and other variants?
The World Health Organization states that currently approved COVID-19 vaccines are expected to remain effective against the NB.1.8.1 variant.
In a webpage dated Jan. 7, 2025, the CDC advises that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine.
It also suggests that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID, should get the vaccine, especially.
However, Health and Human Services Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process.
Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection.
This could mean that some who still wish to receive the vaccine may have to pay out of pocket, if they are able to access it at all. It is not yet known how accessible the COVID-19 vaccine will be moving forward.
How to (still) get a COVID-19 test for free
Increasing Community Access to Testing, Treatment and Response (ICATT), a federal program, continues to provide free COVID-19 testing to individuals without health insurance.
According to the CDC, as of May 27, more than 19,000 locations across the country offer free testing. To find a location near you that offers free testing, visit testinglocator.cdc.gov/Search.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
40 minutes ago
- UPI
'Inverse' vaccines may hold key to challenge autoimmune diseases
1 of 3 | Reverse or inverse vaccines work differently from conventional immunizations like the flu shot and currently available immunosuppressant treatments for autoimmune conditions. Photo by RF._.studio/ Pexels NEW YORK, June 30 (UPI) -- For the millions of Americans battling autoimmune disorders, new hope may be on the horizon in the form of reverse or inverse vaccines -- injections that target a specific part of the immune system. experts told UPI. However, these injections work differently from conventional immunizations like the flu shot and currently available immunosuppressant treatments for autoimmune conditions. They work by targeting only the specific part of the immune system that's behind diseases such as lupus, multiple sclerosis, psoriasis, rheumatoid arthritis and Type 1 diabetes, the experts say. "Inverse vaccines are being developed to treat undesired immune responses, [and] for these situations, the body is reacting to something that is not dangerous," said Lonnie Shea, a researcher in biomedical engineering at the University of Michigan who has studied inverse vaccines and worked on some of the key technology behind them. "A vaccine activates an immune response to a specific antigen," Shea told UPI via email. Inverse vaccines are being developed to treat undesired immune responses, [and] for these situations, the body is reacting to something that is not dangerous. Essentially, an inverse vaccine "aims to decrease the response to a specific antigen, like insulin in Type 1 diabetes," he added. First line of defense When healthy, the immune system is the body's first line of defense against diseases such as cancer and infections caused by viruses and bacteria, according to the National Institutes of Health. However, if the immune system isn't working properly, it can erroneously attack healthy cells, tissues and organs, causing autoimmune diseases that can affect any part of the body, weakening function and potentially leading to death, the NIH says. More than 80 autoimmune diseases are known, some of which are caused by exposure to environmental toxins and have no discovered cure. At least 15 million people in the United States, or about 5% of the population, have an autoimmune disease, the agency reports. Although no cure exists for these conditions, symptoms can be managed with drugs called immunosuppressants, which as the name suggests "broadly reduces your immune system response," Shea said. These drugs, which are typically administered via monthly injections, can have significant side effects, including making those taking them more susceptible to infections, according to the NIH. Many people taking them also have to be careful taking traditional vaccines, such as flu shot or COVID-19 shots because of their impact on the immune system. Training the immune system Developed by researchers at the University of Chicago and elsewhere, inverse vaccines use synthetic nanoparticles attached to specific disease-related proteins, or antigens, to train certain parts of the immune system to behave differently, limiting the attacks that cause autoimmune diseases, neurologist Dr. Lawrence Steinman said. With the inverse vaccines currently being studied, the nanoparticles are designed to mimic human cell death, which is a normal process in the human body, according to the 2021 study that first documented their effectiveness in people with celiac disease, another autoimmune disorder. Dying cells are considered foreign bodies, but the human immune system knows not to attack them. As a result, with the nanoparticles in inverse vaccines, the immune system can be trained not to attack them, or the proteins attached to them, which effectively short-circuits the process behind autoimmune diseases, Steinman said. "Instead of immunizing the recipient to a viral infection, the inverse vaccine tolerizes the immune system, so it will not attack our own tissues," Steinman, who has written about inverse vaccines, told UPI in an email. Several companies are running clinical trials of inverse vaccines, including Cour Pharma, which recently completed successful phase 2 clinical trials for their use in celiac disease and another autoimmune disease, primary biliary cholangitis, according to Shea at the University of Michigan, one of the researchers who started the company. Additional trials -- phase 2 studies are the second stage in the drug research and development process -- are starting for myasthenia gravis and Type 1 diabetes, he added. Although more research is needed before the shots become available, a process that could take five years or more, inverse vaccines offer key advantages, Shea said. For example, unlike immunosuppressants with their monthly dosing, the effects of inverse vaccines appear to last longer, perhaps for as much as a year, similar to conventional vaccines, research suggests. They may also work for people with severe, life-threatening allergies, such as peanut allergies, according to Shea, who has published a study in this area using mice. However, there's also the "risk that instead of tolerizing the human immune system to the target, the process induces conventional immunization, which would make autoimmune conditions like Type 1 diabetes and multiple sclerosis worse," Steinman said. However, "We have come close to success in some early-stage trials," he said "Thus far, none of the results are sufficiently robust for submission in the FDA approval process."
CBS News
an hour ago
- CBS News
HHS eliminates CDC staff who made sure birth control is safe for women at risk
For Brianna Henderson, birth control isn't just about preventing pregnancy. The Texas mother of two was diagnosed with a rare and potentially fatal heart condition after having her second child. In addition to avoiding another pregnancy that could be life-threatening, Henderson has to make sure the contraception she uses doesn't jeopardize her health. For more than a decade, a small team of people at the Centers for Disease Control and Prevention worked to do just that, issuing national guidelines for clinicians on how to prescribe contraception safely for millions of women with underlying medical conditions — including heart disease, lupus, sickle cell disease, and obesity. But the Department of Health and Human Services, which oversees the CDC, fired those workers as part of the Trump administration's rapid downsizing of the federal workforce. It also decimated the CDC's larger Division of Reproductive Health, where the team was housed — a move that clinicians, advocacy groups, and fired workers say will endanger the health of women and their babies. Clinicians said in interviews that counseling patients about birth control and prescribing it is relatively straightforward. But for women with conditions that put them at higher risk of serious health complications, special care is needed. "We really were the only source of safety monitoring in this country," said one fired CDC staffer who worked on the guidelines, known as the U.S. Medical Eligibility Criteria for Contraceptive Use, or MEC. "There's no one who can actually do this work." KFF Health News agreed not to name this worker and others who were not authorized to speak to the press and feared retaliation. The stakes are high for people like Henderson. About six weeks after having her second baby, she said, her heart "was racing." Brianna Henderson poses for a portrait with her husband, Tech Henderson, and children, Rafael Bowens Jr. and Talaycia Henderson, outside their home in Grandview, Texas, on Tuesday, June 17, 2025. Brianna Henderson has become an advocate for educating women about peripartum cardiomyopathy, the rare and potentially fatal heart condition she was diagnosed with after the birth of her second child. Desiree Rios for KFF Health News "I feel like I'm underwater," Henderson said. "I felt like I couldn't breathe." She eventually went to the hospital, where she was told she was "in full-blown heart failure," she said. Henderson was diagnosed with peripartum cardiomyopathy, an uncommon type of heart failure that can happen toward the end of pregnancy or shortly after giving birth. Risk factors for the condition include being at least 30 years old, being of African descent, high blood pressure, and obesity. The CDC contraception guidelines say that combined hormonal contraception, which contains both estrogen and progestin to prevent pregnancy, can pose an "unacceptable health risk" for most women with peripartum cardiomyopathy, also known as PPCM. For some women with the diagnosis, a birth control injection commonly known by the brand name Depo-Provera also carries risks that outweigh its benefits, the guidelines show. Progestin-only pills or a birth control implant, inserted into a person's arm, are the safest. Henderson said her cardiologist had to greenlight which contraception she could use. She uses a progestin-only birth control implant that's more than 99% effective in preventing pregnancy. "I didn't know that certain things can cause blood clots," Henderson said, "or make your heart failure worse." Heart failure is a leading cause of maternal mortality and morbidity in the U.S., with PPCM accounting for up to 70% of heart failure cases during pregnancy. Sweeping HHS layoffs in late March and early April gutted the CDC's reproductive health division, upending several programs designed to protect women and infants, three fired workers said. About two-thirds of the division's roughly 165 employees and contractors were cut, through firings, retirements, or reassignments to other parts of the agency, one worker said. Among those fired were CDC staffers who carried out the Pregnancy Risk Assessment Monitoring System, a survey established nearly 40 years ago to improve maternal and infant health outcomes by asking detailed questions of women who recently gave birth. The survey was used "to help inform and help reduce the contributing factors that cause maternal mortality and morbidity," one fired worker said, by allowing government workers to examine the medical care people received before and during pregnancy, if any, and other risk factors that may lead to poor maternal and child health. The firings also removed CDC workers who collected and analyzed data on in vitro fertilization and other fertility treatments. "They left nothing behind," one worker said. U.S. contraception guidelines were first published in 2010, after the CDC adapted guidance developed by the World Health Organization. The latest version was published in August 2024. It includes information about the safety of different types of contraception for more than 60 medical conditions. Clinicians said it is the premier source of evidence about the safety of birth control. "It gave us so much information which was not available to clinicians at their fingertips," said Michael Policar, a physician and professor of obstetrics, gynecology, and reproductive sciences at the University of California-San Francisco School of Medicine. "If you've got a person with, let's say, long-standing Type 2 diabetes, someone who has a connective-tissue disease like lupus, someone who's got hypertension or maybe has been treated for a precursor to breast cancer — something like that? In those circumstances," Policar said, "before the MEC it was really hard to know how to manage those people." The CDC updates the guidelines comprehensively roughly every five years. On a weekly basis, however, government workers would monitor evidence about patients' use of contraception and the safety of various methods, something they were doing when HHS abruptly fired them this spring, two fired workers said. That work isn't happening now, one of them said. Sometimes the agency would issue interim changes outside the larger updates if new evidence warranted it. Now, if something new or urgent comes up, "there's not going to be any way to update the guidelines," one fired worker said. In 2020, for example, the CDC revised its contraception recommendations for women at high risk of HIV infection, after new evidence showed that various methods were safer than previously thought. HHS spokesperson Emily Hilliard declined to say why CDC personnel working on the contraception guidelines and other reproductive health issues were fired, or answer other questions raised by KFF Health News' reporting. Most women of reproductive age in the U.S. use contraception. CDC data from 2019, the most recent available, shows that more than 47 million women ages 15 to 49 relied on birth control. About 1 in 10 used long-acting methods such as intrauterine devices and implants; 1 in 7 used oral contraception. The latest guidelines included updated safety recommendations for women who have sickle cell disease, lupus, or PPCM, and those who are breastfeeding, among others. Clinicians are now being told that combined hormonal contraception poses an unacceptable health risk for women with sickle cell disease, because it might increase the risk of blood clots. "It can really come down to life or death," said Teonna Woolford, CEO of the Sickle Cell Reproductive Health Education Directive, a nonprofit that advocates for improved reproductive health care for people with the disease. "We really saw the CDC guidelines as a win, as a victory — they're actually going to pay attention," she said. The 2024 guidelines also for the first time included birth control recommendations for women with chronic kidney disease. Research has shown that such women are at higher risk of serious pregnancy complications, including preeclampsia and preterm delivery. Their medical condition also increases their risk of blood clots, which is why it's important for them to not use combined hormonal contraception, fired CDC workers and clinicians said. The CDC information "is the final say in safety," said Patty Cason, a family nurse practitioner and president of Envision Sexual and Reproductive Health. Having only static information about the safety of various types of birth control is "very scary," she said, because new evidence could come out and entirely new methods of contraception are being developed. Henderson said it took her heart two years to recover. She created the nonprofit organization Let's Talk PPCM to educate women about the type of heart failure she was diagnosed with, including what forms of birth control are safe. "We don't want blood clots, worsening heart failures," Henderson said. "They already feel like they can't trust their doctors, and we don't need extra." KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.
Yahoo
an hour ago
- Yahoo
New COVID-19 variant Nimbus spreads across the US, here's what to know in Georgia
A new version of COVID-19 that hardly anyone had heard of a few months ago is spreading quickly in the nation after first being detected in China earlier this year. The variant, called NB.1.8.1 or "Nimbus," did show up in the U.S. until May. But now, health officials estimate it makes up about 37% of current COVID-19 cases, according to the Centers for Disease Control and Prevention (CDC). That's just behind the most common variant right now, LP.8.1, which is a type of Omicron and accounts for 38% of cases. NB.1.8.1 is a newer version of a variant that's already been spreading. Experts say it might spread more easily and could be a little better at getting around the body's defenses, especially for people who've had COVID before or had a vaccine in the past, according to USA TODAY. The World Health Organization says the overall risk from this variant is low right now, but they're still watching it closely. So far, this new variant seems to cause the same types of symptoms as earlier versions of COVID-19. These can include: Fever or chills Cough Runny nose or congestion Sore throat Fatigue (feeling very tired) Headache Muscle aches Trouble breathing Some people have reported an especially bad sore throat, so painful that some are calling it 'razor blade throat." No. However, the state reported 2,574 COVID-19 cases over a two-week span, according to data from the Georgia Department of Public Health last updated on March 27, according to Patch. To find a location near you that offers free testing in Georgia, visit Vanessa Countryman is the Trending Topics Reporter for the Deep South Connect Team Georgia. Email her at Vcountryman@ This article originally appeared on Savannah Morning News: What to know about the new COVID-19 variant Nimbus, as it spreads in US
